Literature DB >> 2531013

Centrally administered atrial natriuretic factor inhibits central angiotensin-induced natriuresis.

P Rohmeiss1, G Demmert, R Rettig, T Unger.   

Abstract

Atrial natriuretic factor (ANF) and angiotensin II (ANG II) have been demonstrated in close vicinity in forebrain areas involved in the central fluid and electrolyte regulation. Previous reports suggested an inhibitory effect of ANF on some of the central actions of ANG II, such as water intake and vasopressin release. In the present study in conscious, unrestrained, sodium-repleted rats we investigated the effects of intracerebroventricularly (i.c.v.) administered ANF (alpha r-APIII) on the central natriuretic action of ANG II. Urine was collected through a novel chronically implanted ureteral catheter. I.c.v. injections of ANG II (100 pg) produced a marked natriuresis of rapid onset without altering urinary volume or blood pressure. Pretreatment with ANF (100 pg, 1 ng, 100 ng i.c.v.) 5 min before ANG II dose-dependently antagonized the ANG II-induced natriuretic effect. The lowest dose caused approximately 50% reduction, the intermediate dose a complete abolition and the highest dose even a reversal of the ANG II-induced natriuretic effect to salt retention. Urinary volume and blood pressure were not altered by the combined treatment with ANG II and ANF. Our results support the idea of a functional antagonism between ANG II and ANF in the central fluid and electrolyte control.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2531013     DOI: 10.1016/0006-8993(89)90476-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

Review 1.  Atrial natriuretic peptide (ANP) as a neuropeptide: interaction with angiotensin II on volume control and renal sodium handling.

Authors:  T Unger; E Badoer; C Gareis; R Girchev; M Kotrba; F Qadri; R Rettig; P Rohmeiss
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 2.  Are angiotensin receptor blockers neuroprotective?

Authors:  Christa Thöne-Reineke; Mathias Zimmermann; Christian Neumann; Maxim Krikov; Jun Li; Nadja Gerova; Thomas Unger
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.